There is an abundant amount of information coming to providers over maintenance therapy for HRP patients in ovarian cancer. Please join us while we review VITAL, GOG 218, and PRIMA study designs, outcomes and conclusions with experts in our field while we explore their perspectives and interpretations on the topics. 

Speakers:
Rodney Rocconi, MD, University of Alabama at Birmingham
Barbara Norquist, MD, University of Washington 
Susan Modesitt, MD, FACOG, FACS, Emory University 

Moderators:
Whitney Goldsberry, MD, University of Louisville

Renata Urban, MD, University of Washington